Status:
COMPLETED
Developmental Dyslexia and Remediation Methods
Lead Sponsor:
Fondation Lenval
Conditions:
Dyslexia, Developmental
Eligibility:
All Genders
8-13 years
Phase:
NA
Brief Summary
At least, three theoretical frameworks are currently involved in therapeutic research in developmental dyslexia. Each theoretical framework relies on the type of underlying cognitive processes that is...
Detailed Description
Developmental dyslexia is defined as a specific and lasting reading learning disorder. This neurodevelopmental disorder has a severe impact on overall academic learning and behavior, compromises profe...
Eligibility Criteria
Inclusion
- Age ≥ 8 years old and ≤ at 13 years old;
- Diagnosis of dyslexia validated by performances ≤ at -1.5 standard deviations from the mean on leximetric tests.
- Diagnosis of mixed dyslexia validated by performances ≤ at -1.5 standard deviations from the mean for reading irregular words and pseudo-words in the Evalec© test.
- Performance ≤ at -1.5 standard deviations from the mean for phonological (Evalec©) and visual-attentional tasks in the Evadys© and Sigl© tests.
- Home equipped with a connected computer system for daily training.
- Signing of informed consent by the parents
- The child must be affiliated to a social security scheme
Exclusion
- Intellectual retardation, neurological disorders, pervasive developmental disorder;
- Primary sensory deficit;
- Educational deficiencies;
- attention deficit hyperactivity disorder, dysphasia;
- Previous daily phonological or visual-attentional training.
Key Trial Info
Start Date :
October 25 2019
Trial Type :
INTERVENTIONAL
Allocation :
ACTUAL
End Date :
December 12 2022
Estimated Enrollment :
145 Patients enrolled
Trial Details
Trial ID
NCT04028310
Start Date
October 25 2019
End Date
December 12 2022
Last Update
September 29 2023
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
Hôpitaux Pédiatriques de Nice CHU-Lenval
Nice, France